How big is the China Precision Medicine Market?

The China Precision Medicine Market size is expected to reach USD 6.20 billion in 2024 and grow at a CAGR of 12.70% to reach USD 11.20 billion by 2029. Read More

What is the current China Precision Medicine Market size?

In 2024, the China Precision Medicine Market size is expected to reach USD 6.20 billion. Read More

Who are the key players in China Precision Medicine Market?

F Hoffmann-La Roche AG, Zhongyuan Union Stem Cell Bioengineering, Amoy Diagnostics, New Horizon Health Ltd and Berry Genomics are the major companies operating in the China Precision Medicine Market. Read More

What years does this China Precision Medicine Market cover, and what was the market size in 2023?

In 2023, the China Precision Medicine Market size was estimated at USD 5.41 billion. The report covers the China Precision Medicine Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the China Precision Medicine Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

China Precision Medicine Market Share

Single User License

~~$4750~~

Team License

~~$5250~~

Corporate License

~~$8750~~

Buy Now

Book before:

Market Share of China Precision Medicine Industry

The market for precision medicine in China is moderately consolidated with the presence of several companies in the country. These companies work both globally and locally in the precision medicine market. Some of the companies are F Hoffmann-La Roche AG, New Horizon Health Ltd, Amoy Diagnostics, Berry Genomics, and Zhongyuan Union Stem Cell Bioengineering.

China Precision Medicine Market Leaders

F Hoffmann-La Roche AG
Zhongyuan Union Stem Cell Bioengineering
Amoy Diagnostics
New Horizon Health Ltd
Berry Genomics

*Disclaimer: Major Players sorted in no particular order

China Precision Medicine Market Concentration